📍 We’re heading to Desert Foot East! 🗓️ April 5th-6th, 2025 📍 Marriott at Glenpointe, NJ BioStem is proud to attend Desert Foot East, where the nation's top clinicians, researchers, and innovators in limb salvage and wound care come together. We’re excited to showcase how our cutting-edge amniotic tissue allografts—VENDAJE, VENDAJE AC, and AmnioWrap2—are transforming outcomes in chronic wound management. Stop by our booth to learn about our BioREtain™ process, experience our interactive 3D technology, and see how BioStem is redefining healing. Let’s connect, collaborate, and advance wound care—together. #DesertFootEast #WoundCareInnovation #LimbSalvage #BioStem #VENDAJE #AmnioWrap2 #BioREtain #ChronicWounds #HealingRedefined #BSEM
BioStem Technologies (OTC: BSEM)
Biotechnology
Pompano Beach, FL 2,582 followers
We Manufacture Products That Change Lives
About us
BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies. The Company is focused on manufacturing products that change lives, leveraging its proprietary BioRetain processing method. BioRetain has been developed by applying the latest research in regenerative medicine, focused on maintaining growth factors and preserving tissue structure. BioStem Technologies' quality management system and standard operating procedures have been reviewed and accredited by the American Association of Tissue Banks ("AATB"). These systems and procedures are established per current Good Tissue Practices ("cGTP") and current Good Manufacturing Processes ("cGMP"). Our portfolio of quality brands includes VENDAJE, VENDAJE AC, and VENDAJE OPTIC. Each BioStem Technologies placental allograft is processed at the Company's FDA registered and AATB accredited site in Pompano Beach, Florida.
- Website
-
http://www.biostemtechnologies.com
External link for BioStem Technologies (OTC: BSEM)
- Industry
- Biotechnology
- Company size
- 11-50 employees
- Headquarters
- Pompano Beach, FL
- Type
- Public Company
- Founded
- 2014
- Specialties
- Biotechnology, Stem Cell Therapy, and Regenerative Medicine
Locations
-
Primary
2836 Center Port Circle
Pompano Beach, FL 33064, US
Employees at BioStem Technologies (OTC: BSEM)
-
Tom Dugan
Partner at 360 Life Sciences Advisors/Chairman and CEO
-
Michael Fortunato, CPA
CFO at BioStem Technologies | CPA, SEC Reporting, M&A Due Diligence
-
Patrick Daly
Global VP & GM @ IQVIA | Executive Advisor, MedTech Pappas Capital
-
Brandon Poe
Chief Financial Officer at Midi Health
Updates
-
🩹 Wound care isn’t one-size-fits-all—and neither is BioStem’s approach. From chronic diabetic ulcers to acute surgical wounds, every wound presents unique challenges. That’s why BioStem offers amniotic tissue allografts designed to meet the diverse needs of wound care professionals. ➡️ In our latest blog, we break down how our products—VENDAJE® and VENDAJE AC®,—can be used as a covering in the treatment of a variety of wounds. ✅ Chronic Wounds ✅ Acute Traumatic Wounds ✅ Surgical Wounds ✅ Burn Wounds 📖 Dive in and learn how BioStem is simplifying wound complexity with innovation and science. 🔗 https://hubs.ly/Q03fmYV50 #WoundCare #ChronicWounds #AcuteWounds #Allografts #BioREtain #BioStem #VENDAJE #HealingInnovation #BSEM
-
-
🚨 Big news from BioStem Technologies! 🚨 We’re proud to announce that the United States Patent and Trademark Office (USPTO) has issued Notices of Allowance for two new U.S. patent applications! 🇺🇸🧬 🔬 These patents strengthen our intellectual property portfolio to: ✅ 43 issued patents ✅ 26 pending applications 💡 The new patents protect innovations in: 🧫 Micronized placental compositions ⚙️ Our proprietary BioREtain® processing method This is a major step forward in our mission to revolutionize wound care. 🌱💉 👉 Read the full press release: https://lnkd.in/eW372sZw #BioStem #Innovation #WoundCare #RegenerativeMedicine #Biotech #Patents #IntellectualProperty #BioREtain #HealingStartsHere #BSEM
-
-
🚨 NEWS: BioStem Technologies is proud to announce our participation in the 24th Annual Needham Virtual Healthcare Conference! 🎤 Our CEO, Jason Matuszewski, will present on Thursday, April 10th at 1:30 PM ET, sharing BioStem’s breakthrough advancements in wound care and the power of our proprietary BioREtain™ processing technology. 🎯 Register to attend and learn why 2024 was a breakout year—and how we're continuing to transform wound care. 📢 Full release: https://lnkd.in/ehQGFTcB #BioStem #RegenerativeMedicine #WoundCare #NeedhamHealthcareConference #BioREtain #HealthcareInnovation #BSEM
-
-
👣 Headed to ACFAS 2025 in Phoenix? So are we! Visit our booth and explore how our advanced amniotic tissue allografts are elevating standards in foot and ankle wound care. 🔬 Learn about our proprietary BioREtain® process 📈 Review clinical data and real-world outcomes for DFUs, VLUs, and post-op healing ☕️ Grab a Starbucks coffee card on us while you're there. Let’s discuss evidence-based solutions for complex wounds. #ACFAS2025 #WoundCare #FootAndAnkle #AmnioticAllografts #BioStem
-
-
How's your bracket...is your school still in? Who are you rooting for? #marchmadness
-
-
BioStem Technologies (OTC: BSEM) reposted this
This article explores Project EPIC — a proposed national policy framework that modernizes reimbursement for skin substitutes, protects patient access, and aligns innovation with clinical evidence, with insights from BioStem Technologies’ leadership.
-
🎉 Happy 1-Year Work Anniversary, Milan Hejda! 🎉 Milan joined BioStem one year ago as our Controller, and from day one, he’s been an absolute powerhouse. Whether it's staying late to close the books, or diving deep into the numbers—Milan does it all with precision, dedication, and a quiet determination that keeps everything running smoothly. We’re incredibly grateful to have someone as committed and dependable as Milan on the team. Here’s to year one—and many more to come! #WorkAnniversary #TeamBioStem #FinanceLeader #BioStemStrong #BSEM
-
-
BioStem Technologies (OTC: BSEM) reposted this
Grateful to have participated today in the BioFlorida 2025 Showcase in #Miami, discussing "South Florida Commercial Success." It was a pleasure sharing insights alongside Maurice R. Ferre M.D., CEO & Chairman of INSIGHTEC. Special thanks to BioFlorida, Inc. and Mark Glickman for organizing this impactful event and fostering collaboration and growth in Florida's thriving life sciences community. Looking forward to continued innovation and partnerships! #Miami #LifeSciences #Innovation #BioFlorida #CommercialSuccess #Collaboration